What is NVS's market cap?

$302.65B, based on the Nov 12 close of $160.25.

What is NVS's P/E ratio?

44.8× trailing-twelve-month earnings of $6.76B.

Does Novartis AG pay a dividend?

Yes. The latest regular dividend was $4.74 per share (ex-date Mar 11), an annualised yield of 2.96%.

NYSE · NVS

Novartis AG (NVS)

$160.25−0.04%

Close Nov 12, 2026 · split-adjusted

Nov 12, 2026$160.25▲ 21.14% in range

Nov 12, 2025Low $124.36 · High $168.62Nov 12, 2026

What changed · written from our data

As of Nov 12, 2026

Novartis AG closed at $160.25 on Nov 12, down 0.04%, 5.0% below its 52-week closing high. Volume of 2.1M shares was 0.97× its 20-day average (close to normal).

Split-adjusted performance: +9.1% over one month, +7.0% over six months, +22.8% over one year.

In the quarter ended Jun 30, 2016, revenue was $12.68B, down 1.7% from a year earlier, with a net margin of 14.2%.

Short interest was 4.5M shares at the Oct 30 settlement, down 19.2% from the prior report (1.9 days to cover).

Market cap$302.65B1.89B shares

Revenue · quarter$12.68B−1.7% YoY

Diluted EPS$0.750.0% YoY

P/E · TTM44.8×P/S 6.1×

Net margin14.2%Gross 64.9%

Dividend yield2.96%$4.7402 last paid

52-week range124.36 – 168.62−5.0% from high

Volume2.1M0.97× 20-day avg

Volatility · 60d39.7%Annualised

Short % of float—1.9 days to cover

Net cash$5.83BCash $11.44B

Next earnings—Not scheduled

Split-adjusted performance

1W −1.0%1M +9.1%3M +6.2%6M +7.0%YTD +16.2%1Y +22.8%3Y +70.8%5Y +91.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short4.5M−19.2% vs prior

Days to cover1.9Settled Oct 30

% of float—

Short vol. 10d52.7%of daily volume

News about Novartis AG

All news →

Are You Looking for a Top Momentum Pick? Why Novartis (NVS) is a Great ChoiceZacks Investment Research · 23h ago▲ Positive Novartis ranks first place in 2026 Access to Medicine IndexGlobeNewswire Inc. · 3d ago▲ Positive Zacks Industry Outlook Highlights Eli Lilly, Novartis and BayerZacks Investment Research · 3d ago▲ Positive Novartis: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · Nov 4, 2026▲ Positive All You Need to Know About Novartis (NVS) Rating Upgrade to BuyZacks Investment Research · Oct 30, 2026▲ Positive

Quick answers

What does Novartis AG do?: Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic.
What is NVS's market cap?: $302.65B, based on the Nov 12 close of $160.25.
What is NVS's P/E ratio?: 44.8× trailing-twelve-month earnings of $6.76B.
Does Novartis AG pay a dividend?: Yes. The latest regular dividend was $4.74 per share (ex-date Mar 11), an annualised yield of 2.96%.

About Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

75,267 employeesListed Nov 7, 1996novartis.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology